Handa Pharmaceuticals, Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was TWD 13.749 million compared to TWD 13.253 million a year ago. Operating loss was TWD 125.091 million compared to TWD 153.897 million a year ago. Net loss was TWD 116.613 million compared to TWD 145.403 million a year ago. Basic loss per share was TWD 1.01 compared to TWD 1.26 a year ago.